Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.

Gastroenterology - 1 Sept 2011

Habersetzer François, Honnet Géraldine, Bain Christine, Maynard-Muet Marianne, Leroy Vincent, Zarski Jean-Pierre, Feray Cyrille, Baumert Thomas F, Bronowicki Jean-Pierre, Doffoël Michel, Trépo Christian, Agathon Delphine, Toh Myew-Ling, Baudin Martine, Bonnefoy Jean-Yves, Limacher Jean-Marc, Inchauspé Geneviève

Abstract excerpt

BACKGROUND & AIMS: Therapy for chronic hepatitis C (CHC) has limited efficacy, adverse effects, and high costs. Cohort and vaccine-based preclinical studies have indicated the importance of T-cell-based immunity in controlling viral infection. TG4040 is a recombinant poxvirus vaccine that express...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-gamma

Share to T-Lymphocytes

Share to Viral Load

Share to Viral Nonstructural Proteins

Share to Viral Vaccines

Source

Identifiers

PMID: 21699798
DOI: 10.1053/j.gastro.2011.06.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21699798-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.PMID 21699798Read ↗

Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.Semantic proximity Read ↗

Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.Semantic proximity Read ↗

Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.Semantic proximity Read ↗

Sequence analysis of the hepatitis C virus (HCV) core gene suggests the core protein as an appropriate target for HCV vaccine strategies.Semantic proximity Read ↗

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.Semantic proximity Read ↗

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.Semantic proximity Read ↗

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.Semantic proximity Read ↗

Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.Semantic proximity Read ↗

Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination.Semantic proximity Read ↗

Modulation of the Immune Response Induced by Gene Electrotransfer of a Hepatitis C Virus DNA Vaccine in Nonhuman PrimatesSemantic proximity Read ↗

A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.Semantic proximity Read ↗

Removal of the C6 vaccinia virus interferon-β inhibitor in the hepatitis C vaccine candidate MVA-HCV elicited in mice high immunogenicity in spite of reduced host gene expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.